159 related articles for article (PubMed ID: 22367470)
1. MRI of the breast in patients with DCIS to exclude the presence of invasive disease.
Deurloo EE; Sriram JD; Teertstra HJ; Loo CE; Wesseling J; Rutgers EJ; Gilhuijs KG
Eur Radiol; 2012 Jul; 22(7):1504-11. PubMed ID: 22367470
[TBL] [Abstract][Full Text] [Related]
2. Is breast magnetic resonance imaging (MRI) useful for diagnosis of additional sites of disease in patients recently diagnosed with pure ductal carcinoma in situ (DCIS)?
Benveniste AP; Ortiz-Perez T; Ebuoma LO; Sepulveda KA; Severs FJ; Roark A; Wang T; Sedgwick EL
Eur J Radiol; 2017 Nov; 96():74-79. PubMed ID: 29103479
[TBL] [Abstract][Full Text] [Related]
3. Application of magnetic resonance computer-aided diagnosis for preoperatively determining invasive disease in ultrasonography-guided core needle biopsy-proven ductal carcinoma in situ.
Ahn HS; Kim SM; Kim MS; Jang M; Yun B; Kang E; Kim EK; Park SY; Kim B
Medicine (Baltimore); 2020 Jul; 99(31):e21257. PubMed ID: 32756104
[TBL] [Abstract][Full Text] [Related]
4. MRI findings of cancers preoperatively diagnosed as pure DCIS at core needle biopsy.
Huang YT; Cheung YC; Lo YF; Ueng SH; Kuo WL; Chen SC
Acta Radiol; 2011 Dec; 52(10):1064-8. PubMed ID: 21969708
[TBL] [Abstract][Full Text] [Related]
5. Predictors of invasive disease in patients preoperatively diagnosed with ductal carcinoma without stromal invasion, with breast magnetic resonance imaging (MRI) and ultrasound (US).
Maeda H; Hayashida T; Watanuki R; Kikuchi M; Nakashoji A; Yokoe T; Seki T; Takahashi M; Kitagawa Y
Breast Cancer; 2021 Mar; 28(2):398-404. PubMed ID: 33200381
[TBL] [Abstract][Full Text] [Related]
6. Preoperative clinicopathologic factors and breast magnetic resonance imaging features can predict ductal carcinoma in situ with invasive components.
Lee CW; Wu HK; Lai HW; Wu WP; Chen ST; Chen DR; Chen CJ; Kuo SJ
Eur J Radiol; 2016 Apr; 85(4):780-9. PubMed ID: 26971424
[TBL] [Abstract][Full Text] [Related]
7. The role of breast MR imaging in pre-operative determination of invasive disease for ductal carcinoma in situ diagnosed by needle biopsy.
Goto M; Yuen S; Akazawa K; Nishida K; Konishi E; Kajihara M; Shinkura N; Yamada K
Eur Radiol; 2012 Jun; 22(6):1255-64. PubMed ID: 22205445
[TBL] [Abstract][Full Text] [Related]
8. MR features to suggest microinvasive ductal carcinoma of the breast: can it be differentiated from pure DCIS?
Hahn SY; Han BK; Ko EY; Shin JH; Hwang JY; Nam M
Acta Radiol; 2013 Sep; 54(7):742-8. PubMed ID: 23588154
[TBL] [Abstract][Full Text] [Related]
9. The role of MRI and clinicopathologic features in predicting the invasive component of biopsy-confirmed ductal carcinoma in situ.
Yoon GY; Choi WJ; Cha JH; Shin HJ; Chae EY; Kim HH
BMC Med Imaging; 2020 Aug; 20(1):95. PubMed ID: 32787871
[TBL] [Abstract][Full Text] [Related]
10. Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ.
Takada K; Kashiwagi S; Asano Y; Goto W; Morisaki T; Takahashi K; Fujita H; Takashima T; Tomita S; Hirakawa K; Ohira M
BMC Cancer; 2020 Jun; 20(1):513. PubMed ID: 32493410
[TBL] [Abstract][Full Text] [Related]
11. BI-RADS MRI enhancement characteristics of ductal carcinoma in situ.
Rosen EL; Smith-Foley SA; DeMartini WB; Eby PR; Peacock S; Lehman CD
Breast J; 2007; 13(6):545-50. PubMed ID: 17983393
[TBL] [Abstract][Full Text] [Related]
12. Is ductal carcinoma in situ with "possible invasion" more predictive of invasive carcinoma than pure ductal carcinoma in situ?
Arazi-Kleinman T; Causer PA; Nofech-Mozes S; Jong RA
Can Assoc Radiol J; 2012 May; 63(2):146-52. PubMed ID: 21561735
[TBL] [Abstract][Full Text] [Related]
13. Can Occult Invasive Disease in Ductal Carcinoma In Situ Be Predicted Using Computer-extracted Mammographic Features?
Shi B; Grimm LJ; Mazurowski MA; Baker JA; Marks JR; King LM; Maley CC; Hwang ES; Lo JY
Acad Radiol; 2017 Sep; 24(9):1139-1147. PubMed ID: 28506510
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors for the presence of invasive components in patients diagnosed with ductal carcinoma in situ based on preoperative biopsy.
Lee KH; Han JW; Kim EY; Yun JS; Park YL; Park CH
BMC Cancer; 2019 Dec; 19(1):1201. PubMed ID: 31822268
[TBL] [Abstract][Full Text] [Related]
15. Features of occult invasion in biopsy-proven DCIS at breast MRI.
Wisner DJ; Hwang ES; Chang CB; Tso HH; Joe BN; Lessing JN; Lu Y; Hylton NM
Breast J; 2013; 19(6):650-8. PubMed ID: 24165314
[TBL] [Abstract][Full Text] [Related]
16. Is it possible to predict underestimation in ductal carcinoma in situ of the breast? Yes, using a simple score!
Marques LC; Marta GN; de Andrade JZ; Andrade D; de Barros ACSD; Andrade FEM
Eur J Surg Oncol; 2019 Jul; 45(7):1152-1155. PubMed ID: 30665684
[TBL] [Abstract][Full Text] [Related]
17. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
Yen TW; Hunt KK; Ross MI; Mirza NQ; Babiera GV; Meric-Bernstam F; Singletary SE; Symmans WF; Giordano SH; Feig BW; Ames FC; Kuerer HM
J Am Coll Surg; 2005 Apr; 200(4):516-26. PubMed ID: 15804465
[TBL] [Abstract][Full Text] [Related]
18. Rates of reexcision for breast cancer after magnetic resonance imaging-guided bracket wire localization.
Wallace AM; Daniel BL; Jeffrey SS; Birdwell RL; Nowels KW; Dirbas FM; Schraedley-Desmond P; Ikeda DM
J Am Coll Surg; 2005 Apr; 200(4):527-37. PubMed ID: 15804466
[TBL] [Abstract][Full Text] [Related]
19. Preoperative breast MRI in management of patients with needle biopsy-proven ductal carcinoma in situ (DCIS).
van Bekkum S; Ter Braak BPM; Plaisier PW; van Rosmalen J; Menke-Pluijmers MBE; Westenend PJ
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1854-1860. PubMed ID: 32624292
[TBL] [Abstract][Full Text] [Related]
20. Ductal carcinoma in situ: is there a role for MRI?
Zuiani C; Francescutti GE; Londero V; Zunnui I; Bazzocchi M
J Exp Clin Cancer Res; 2002 Sep; 21(3 Suppl):89-95. PubMed ID: 12585661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
